David Mansfield, an Insider in Perma-Pipe International Holdings, Inc. (PPIH), Unloaded 5398 shares of the Company; Hrt Financial Lifted Lilly Eli & Co (LLY) Stake

June 27, 2018 - By Shannon Black

Eli Lilly and Company (NYSE:LLY) Logo

Hrt Financial Llc increased Lilly Eli & Co (LLY) stake by 424.93% reported in 2018Q1 SEC filing. Hrt Financial Llc acquired 12,748 shares as Lilly Eli & Co (LLY)’s stock rose 3.23%. The Hrt Financial Llc holds 15,748 shares with $1.22M value, up from 3,000 last quarter. Lilly Eli & Co now has $86.90 billion valuation. The stock increased 0.04% or $0.03 during the last trading session, reaching $85.14. About 1.71M shares traded. Eli Lilly and Company (NYSE:LLY) has risen 5.65% since June 27, 2017 and is uptrending. It has underperformed by 6.92% the S&P500. Some Historical LLY News: 07/05/2018 – REG-Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma; 10/05/2018 – Trump plan for drug prices seen largely sparing industry; 23/04/2018 – Eli Lilly: FDA Panel Recommends OK of Baricitinib 2mg, but Not 4mg, to Treat Moderately-to-Severely Active Rheumatoid Arthritis; 04/04/2018 – ELI LILLY – SIGILON ELIGIBLE TO GET SINGLE TO DOUBLE DIGIT TIERED ROYALTIES ON FUTURE PRODUCT SALES IF DEAL YIELDS COMMERCIALLY SUCCESSFUL PRODUCT; 27/04/2018 – ADVANTAGENE – ITS INVESTIGATIONAL GMCI COMBINED WITH OPDIVO IS TO TREAT NEWLY DIAGNOSED MALIGNANT GLIOMA PATIENTS GETTING SURGERY WITH/WITHOUT TEMOZOLOMIDE; 10/04/2018 – Pfizer’s Xeljanz Barrels into Psoriatic Arthritis, Leaving Lilly’s Recently Launched Taltz in its Wake, According to a Recently; 09/03/2018 – Maura Dickler, M.D., to become Vice President of Late Phase Development at Lilly Oncology; 23/03/2018 – Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin®) For The Treatment Of Three Types Of; 16/04/2018 – OPDIVO PLUS LOW-DOSE YERVOY COMBINATION REDUCES RISK OF PROGRES; 16/04/2018 – ASTRAZENECA PLC AZN.L – UPDATED OVERALL SURVIVAL DATA FOR LYNPARZA IN BRCA-MUTATED HER2-NEGATIVE METASTATIC BREAST CANCER PRESENTED AT AACR

Perma-Pipe International Holdings, Inc., together with its subsidiaries, engineers, designs, makes, and sells specialty piping, and leak detection and location systems. The company has market cap of $71.46 million. It offers various piping systems, including industrial and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products; insulated and jacketed piping systems for district heating and cooling; and coating and/or insulation of gas and oil gathering flow and long lines for oil and mineral transportation. It currently has negative earnings. The firm sells its products in the United States, the Middle East, Canada, India, and internationally.

More news for Perma-Pipe International Holdings, Inc. (NASDAQ:PPIH) were recently published by: Businesswire.com, which released: “Perma-Pipe International Holdings, Inc. Announces First Quarter Financial Results” on June 12, 2018. Seekingalpha.com‘s article titled: “More on Perma-Pipe International Q1 results” and published on June 12, 2018 is yet another important article.

The stock decreased 2.63% or $0.25 during the last trading session, reaching $9.25. About 1,337 shares traded. Perma-Pipe International Holdings, Inc. (NASDAQ:PPIH) has risen 25.49% since June 27, 2017 and is uptrending. It has outperformed by 12.92% the S&P500. Some Historical PPIH News: 19/04/2018 – PERMA-PIPE INTERNATIONAL HOLDINGS INC QTRLY SHR LOSS $0.19; 06/04/2018 Perma-Pipe International Holdings Appoints Thierry Jahant Vice President – Oil and Gas International; 19/04/2018 – PERMA-PIPE INTERNATIONAL – ALTHOUGH EAST AFRICA PROJECT IS EXPERIENCING SOME MINOR DELAY, IT IS EXPECTED TO MOVE FORWARD DURING COMING MONTHS; 16/04/2018 – Perma-Pipe International Holdings Appoints William Leong as General Manager – PermAlert; 19/04/2018 – PERMA-PIPE INTERNATIONAL HOLDINGS INC – BACKLOG AT $46.7 MLN AT QTR END; 19/04/2018 – PERMA-PIPE INTERNATIONAL HOLDINGS INC – DO ANTICIPATE AN UPTURN IN LEVELS OF ACTIVITY IN CO’S MARKETS DURING FORTHCOMING YEAR; 25/04/2018 – Perma-Pipe International Holdings Announces that Director Bradley E. Mautner Will Not Stand For Re-Election to Board

The insider David Mansfield who is President and CEO of Perma-Pipe International Holdings Inc sold some 5,398 shares of the public firm having a total value of $48,717 U.S Dollars which is calculated based on a stock price of $9.0 per each share. The Form 4 was unveiled in a filing dated June 27, 2018 with the SEC. Right now, David Mansfield owns 24,990 shares which are about 0.32% of Perma-Pipe International Holdings Inc’s total market cap (Market Capitalization is a measurement of business value based on share price and number of shares outstanding).

More notable recent Eli Lilly and Company (NYSE:LLY) news were published by: 247Wallst.com which released: “Short Sellers Hike Bets in Major Pharma Stocks” on June 27, 2018, also Streetinsider.com with their article: “Boehringer Ingelheim, Lilly (LLY) Announce Phase III for Empagliflozin as Adjunct to Insulin in Type 1 Diabetes Met …” published on June 25, 2018, Streetinsider.com published: “Eli Lilly & Co. (LLY) Highlights New Data from Three Phase 1b Studies Evaluating URLi Compared to Humalog” on June 25, 2018. More interesting news about Eli Lilly and Company (NYSE:LLY) were released by: Streetinsider.com and their article: “Eli Lilly & Co. (LLY) Highlights Promise of Once-Weekly Trulicity (dulaglutide) in Data from Phase 2 study” published on June 25, 2018 as well as Fool.com‘s news article titled: “Is Pfizer’s Lead Growth Driver in Trouble?” with publication date: June 26, 2018.

Investors sentiment decreased to 0.78 in 2018 Q1. Its down 0.32, from 1.1 in 2017Q4. It dived, as 76 investors sold LLY shares while 427 reduced holdings. 82 funds opened positions while 308 raised stakes. 810.94 million shares or 1.95% less from 827.08 million shares in 2017Q4 were reported. Comm National Bank reported 0.12% of its portfolio in Eli Lilly and Company (NYSE:LLY). Goldman Sachs Grp has invested 0.18% in Eli Lilly and Company (NYSE:LLY). Cardinal has 1.18% invested in Eli Lilly and Company (NYSE:LLY) for 48,342 shares. Nj State Employees Deferred Compensation Plan holds 0.48% or 35,000 shares. Df Dent And Communications owns 7,403 shares. Bryn Mawr Trust has 0.18% invested in Eli Lilly and Company (NYSE:LLY) for 40,973 shares. Old National Financial Bank In has invested 2.95% in Eli Lilly and Company (NYSE:LLY). Valueworks Limited Liability Com holds 4.17% in Eli Lilly and Company (NYSE:LLY) or 70,615 shares. Arizona State Retirement reported 280,354 shares. Gulf Int Commercial Bank (Uk) Ltd holds 0.31% of its portfolio in Eli Lilly and Company (NYSE:LLY) for 312,358 shares. Moreover, Ballentine Limited Com has 0.02% invested in Eli Lilly and Company (NYSE:LLY). Taurus Asset Mngmt Limited Co has invested 0.04% in Eli Lilly and Company (NYSE:LLY). Skba Capital Ltd Liability Corporation has 5,200 shares for 0.05% of their portfolio. Secor Cap Advsr Lp accumulated 21,524 shares. Hl Services Limited Co has invested 0.11% in Eli Lilly and Company (NYSE:LLY).

Among 24 analysts covering Eli Lilly and Company (NYSE:LLY), 14 have Buy rating, 1 Sell and 9 Hold. Therefore 58% are positive. Eli Lilly and Company had 107 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Monday, May 2 by Leerink Swann. Atlantic Securities initiated it with “Overweight” rating and $100 target in Friday, December 18 report. The stock has “Buy” rating by SunTrust on Friday, October 27. The company was maintained on Monday, June 11 by J.P. Morgan. Leerink Swann maintained it with “Outperform” rating and $95 target in Monday, December 28 report. BMO Capital Markets maintained the shares of LLY in report on Thursday, February 1 with “Underperform” rating. The stock of Eli Lilly and Company (NYSE:LLY) earned “Hold” rating by Leerink Swann on Wednesday, December 13. BMO Capital Markets upgraded it to “Outperform” rating and $100 target in Monday, November 16 report. The stock of Eli Lilly and Company (NYSE:LLY) earned “Overweight” rating by Barclays Capital on Friday, April 7. Barclays Capital upgraded Eli Lilly and Company (NYSE:LLY) rating on Tuesday, December 1. Barclays Capital has “Overweight” rating and $95 target.

Eli Lilly and Company (NYSE:LLY) Institutional Positions Chart